Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Immuneering Corp | Director | Class A Common Stock | 477K | $1.21M | $2.55 | Mar 22, 2024 | General Partner of PEF LLC. |
Immuneering Corp | Director | Class A Common Stock | 392K | $1M | $2.55 | Mar 22, 2024 | General Partner of PF Associates L.P. |
Immuneering Corp | Director | Class A Common Stock | 115K | $294K | $2.55 | Mar 22, 2024 | General Partner of S4K Investments LLC. |
Immuneering Corp | Director | Class A Common Stock | 112K | $285K | $2.55 | Mar 22, 2024 | Direct |
Notable Labs, Ltd. | Director | Ordinary Shares | 40.2K | May 8, 2024 | Direct | ||
Immuneering Corp | Director | Stock Option | 33.4K | Jun 12, 2024 | Direct | ||
Notable Labs, Ltd. | Director | Stock Option | 9.75K | Jan 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMRX | Immuneering Corp | Jun 12, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
NTBL | Notable Labs, Ltd. | May 8, 2024 | 1 | $0 | 4 | May 10, 2024 | Director |
IMRX | Immuneering Corp | Mar 22, 2024 | 1 | $63.7K | 4 | Mar 25, 2024 | Director |
IMRX | Immuneering Corp | Mar 18, 2024 | 3 | $183K | 4 | Mar 19, 2024 | Director |
NTBL | Notable Labs, Ltd. | Jan 24, 2024 | 1 | $0 | 4 | Jan 26, 2024 | Director |
IMRX | Immuneering Corp | Jan 1, 2024 | 1 | $0 | 4 | Jan 2, 2024 | Director |
VBLT | Notable Labs, Ltd. | Oct 16, 2023 | 0 | $0 | 3 | Oct 18, 2023 | Director |
IMRX | Immuneering Corp | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
IMRX | Immuneering Corp | Jun 21, 2022 | 1 | $0 | 4 | Jun 23, 2022 | Director |
IMRX | Immuneering Corp | Mar 15, 2022 | 1 | $45K | 4 | Mar 16, 2022 | Director |
IMRX | Immuneering Corp | Sep 20, 2021 | 1 | $116K | 4 | Sep 21, 2021 | Director |
IMRX | Immuneering Corp | Sep 13, 2021 | 2 | $131K | 4 | Sep 15, 2021 | Director |
IMRX | Immuneering Corp | Aug 3, 2021 | 12 | $4.38M | 4 | Aug 4, 2021 | Director |
IMRX | Immuneering Corp | Jul 29, 2021 | 0 | $0 | 3/A | Sep 13, 2021 | Director |